Last $3.40 USD
Change Today -0.0668 / -1.93%
Volume 7.1K
ERB On Other Exchanges
Symbol
Exchange
NYSE Amex
Frankfurt
As of 12:35 PM 03/3/15 All times are local (Market data is delayed by at least 15 minutes).

erba diagnostics inc (ERB) Snapshot

Open
$3.47
Previous Close
$3.47
Day High
$3.47
Day Low
$3.40
52 Week High
09/10/14 - $4.13
52 Week Low
04/28/14 - $1.39
Market Cap
149.6M
Average Volume 10 Days
12.6K
EPS TTM
$0.02
Shares Outstanding
44.0M
EX-Date
--
P/E TM
154.5x
Dividend
--
Dividend Yield
--
Current Stock Chart for ERBA DIAGNOSTICS INC (ERB)

Related News

No related news articles were found.

erba diagnostics inc (ERB) Related Businessweek News

No Related Businessweek News Found

erba diagnostics inc (ERB) Details

ERBA Diagnostics, Inc., through its subsidiaries, develops, manufactures, and markets diagnostic test kits or assays, and automated systems that are used to aid in the detection of disease markers primarily in the areas of autoimmune, infectious diseases, clinical chemistry, hematology, and diabetes testing. It manufactures scientific and laboratory instruments, such as Mago 4, Mago 4S, and Mago Plus systems, which perform tests in an automated mode; sells other diagnostic products in Italy; and develops, manufactures, and markets diagnostic equipment, as well as raw materials, such as antigens that are used in the production of diagnostic kits. The company also develops, manufactures, and markets autoimmune reagents and research products for use by research laboratories and commercial diagnostic manufacturers. In addition, the company provides instruments for blood cell counting and blood analysis; supplies reagents and other consumable materials; sells diabetic testing products, including the DS5 instrument, dispenser, and associated reagent kits, which measure long-term glucose control in diabetic patients; and offers equipment for use in the field of human and veterinary hematology. Further, it manufactures and sells liquid stable, diagnostics chemistry reagents used for in vitro diagnostics testing. The company markets its products through its sales force to hospitals, reference laboratories, clinical laboratories, and research laboratories, as well as to other commercial companies that manufacture diagnostic products in the United States; and through sales representatives and independent agents in Italy, as well as through independent distributors internationally. ERBA Diagnostics, Inc. was founded in 1980 and is headquartered in Miami Lakes, Florida. ERBA Diagnostics, Inc. is a subsidiary of ERBA Diagnostics Mannheim GmbH.

135 Employees
Last Reported Date: 04/14/14
Founded in 1980

erba diagnostics inc (ERB) Top Compensated Officers

Chief Executive Officer
Total Annual Compensation: $150.0K
Principal Financial Officer, Principal Accoun...
Total Annual Compensation: $47.4K
Compensation as of Fiscal Year 2013.

erba diagnostics inc (ERB) Key Developments

ERBA Diagnostics, Inc. Attains CE Mark for HB Vario A1c Detection System and Reagents for Management of Diabetes

ERBA Diagnostics, Inc. has attained CE Mark clearance for the HB Vario A1c detection system and associated reagents. Monitoring A1c values can help healthcare providers manage complications from diabetes in patients. The CE Mark registration provides marketing authorization in the 28 member states of the European Union and can be used for registration in additional countries who recognize the CE Mark. Following CE Mark clearance in December 2014, ERBA Diagnostics has commenced a limited launch of the HB Vario A1c detection system and associated reagents in Europe through its direct sales team and a limited launch in India through its distributor, and indirect parent company, Transasia Bio-Medicals. The Hb-Vario is capable of processing up to 10 samples at a time with an assay time of just around 4 minutes per sample. The Hb-Vario can sample from a wide number of sample tubes. The touchscreen of the Hb-Vario, the interactive software and user-friendly features makes the unit extremely easy to use. Diabetes continues to be one of the major challenges worldwide to the healthcare industry, a challenge that is pronounced in developing countries and emerging markets. It is currently estimated by the World Health Organization that 347 million people worldwide are afflicted with diabetes.

ERBA Diagnostics, Inc. Presents at 8th Annual OneMedForum 2015, Jan-12-2015 02:40 PM

ERBA Diagnostics, Inc. Presents at 8th Annual OneMedForum 2015, Jan-12-2015 02:40 PM. Venue: San Francisco Marriott Marquis, Parc 55 Wyndham, Union Square, San Francisco, California, United States. Speakers: Mohan Gopalkrishnan, Chief Executive Officer.

ERBA Diagnostics, Inc. Presents at LD Micro Conference, Dec-04-2014 07:30 AM

ERBA Diagnostics, Inc. Presents at LD Micro Conference, Dec-04-2014 07:30 AM. Venue: Luxe Sunset Boulevard Hotel, 11461 Sunset Boulevard, Los Angeles, California, United States. Speakers: Mohan Gopalkrishnan, Chief Executive Officer.

 

Stock Quotes

Market data is delayed at least 15 minutes.

Company Lookup
Recently Viewed
ERB:US $3.40 USD -0.0668

ERB Competitors

Market data is delayed at least 15 minutes.

Company Last Change
Alere Inc $45.57 USD -0.74
Bio-Rad Laboratories Inc $132.91 USD +0.44
Corgenix Medical Corp $0.27 USD 0.00
DiaSorin SpA €36.00 EUR -0.22
Meridian Bioscience Inc $20.02 USD -0.02
View Industry Companies
 

Industry Analysis

ERB

Industry Average

Valuation ERB Industry Range
Price/Earnings 100.0x
Price/Sales 5.4x
Price/Book 8.2x
Price/Cash Flow 104.7x
TEV/Sales 5.3x
 | 

Sponsored Financial Commentaries

Sponsored Links

Report Data Issue

To contact ERBA DIAGNOSTICS INC, please visit www.erbadiagnostics.com. Company data is provided by Capital IQ. Please use this form to report any data issues.

Please enter your information in the following field(s):
Update Needed*

All data changes require verification from public sources. Please include the correct value or values and a source where we can verify.

Your requested update has been submitted

Our data partners will research the update request and update the information on this page if necessary. Research and follow-up could take several weeks. If you have questions, you can contact them at bwwebmaster@businessweek.com.